Propofol exerts anti-hepatocellular carcinoma by microvesicle-mediated transfer of miR-142-3p from macrophage to cancer cells
Open Access
- 9 October 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 12 (1), 1-9
- https://doi.org/10.1186/s12967-014-0279-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma – A systematic reviewSurgical Oncology, 2013
- MicroRNAs in Hepatocellular Carcinoma: Regulation, Function, and Clinical ImplicationsThe Scientific World Journal, 2013
- Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkersGenes & Development, 2012
- Systematic review of actual 10-year survival following resection for hepatocellular carcinomaHPB, 2012
- Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cellsMolecular Cancer, 2011
- MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cellsFEBS Letters, 2011
- Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell MigrationMolecular Cell, 2010
- Microvesicles: mediators of extracellular communication during cancer progressionJournal of Cell Science, 2010
- Differential effects of propofol and isoflurane on the activation of T‐helper cells in lung cancer patientsAnaesthesia, 2010
- Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinomaInternational Journal of Cancer, 2008